On July 25, 2024, Steve Gorlin notified the Board of Directors (the “Board”) of BioVie Inc. (the “Company”) of his intention to resign as a director of the Company, effective immediately.
Departed
Mitch Hill
Chief Financial Officer
Inari Medical, Inc.
Effective
2024-10-01
Successor
Kevin Strange
Filed
July 30, 2024, 7:59 PM ET
On July 24, 2024, Mitch Hill notified Inari Medical, Inc. (the “Company”) of his decision to retire as Chief Financial Officer of the Company, effective as of October 1, 2024 (the “Effective Date”).
the employment of Dr. Edwin Rock, the Company’s Chief Medical Officer, will end on July 31, 2024
Departed
Christopher Meinerz
Chief Financial Officer
ALPINE 4 HOLDINGS, INC.
Effective
2024-08-30
Successor
Ginger Smith
Filed
July 30, 2024, 7:59 PM ET
Christopher Meinerz, the Company’s Chief Financial Officer, notified Kent Wilson, the Company’s Chief Executive Officer, and the Board of Directors (the “Board”) that Mr. Meinerz intends to resign as the Company’s Chief Financial Officer effective on or by August 30, 2024.
Departed
Michael Nketiah
Senior Vice President of Clinical, Quality, & Regulatory Affairs
On July 29, 2024, Michael Nketiah submitted his resignation as the Senior Vice President of Clinical, Quality, & Regulatory Affairs of Nexalin Technology Inc. (the "Company").
On July 26, 2024, Jonathan M. Tisch also informed the Corporation that he will retire from his position as a member of the Office of the President of the Corporation, effective December 31, 2024.
On July 26, 2024, each of Andrew H. Tisch and Jonathan M. Tisch informed the Corporation that they will retire from their positions as directors, including as Co-Chairmen of the Board of Directors, of the Corporation, effective December 31, 2024.
On July 26, 2024, each of Andrew H. Tisch and Jonathan M. Tisch informed the Corporation that they will retire from their positions as directors, including as Co-Chairmen of the Board of Directors, of the Corporation, effective December 31, 2024.
On July 24, 2024, Michael E. Rescoe, a member of the Board of Directors (the “Board”) of Darling Ingredients Inc. (the “Company”) since 2017, notified the Company and the Board that he was retiring from the Board effective July 24, 2024.
Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.
The Yoon Separation Agreement provides for Mr. Yoon’s continued service as Chief Operating Officer and Special Counsel for a transition period until September 3, 2024 (the “Yoon Separation Date”). Mr. Yoon’s employment will terminate and he will cease to hold any positions with the Company as of the Yoon Separation Date.
On July 28, 2024, Neil McFarlane notified the board of directors of the Company (the “Board”) of his intent to resign from the Board, effective immediately.
Departed
Orla M. Gregory
President
Enstar Group LTD
Effective
2024-12-31
Filed
July 29, 2024, 7:59 PM ET
Orla M. Gregory, President and a member of the Company Board, will leave the Company on December 31, 2024.
On July 23, 2024, Danielle M. Brown notified PRA Group, Inc. (the “Company”) that she was resigning from the Company’s Board of Directors (the “Board”) effective August 1, 2024.
John H. Robinson notified Alliance Resource Management GP, LLC ("MGP"), the general partner of the Partnership, that he will retire from the board of directors of MGP (the "Board of Directors") at the end of the year.
Ms. Hoovel will continue to serve as the Company’s principal accounting officer until her retirement, at which time Ms. Elting will assume the role of Vice President – Corporate Controller.
Tutor Perini Corporation (the “Company”) and Michael F. Smithson, the Company’s former Executive Vice President, Civil Group, have entered into a Separation Agreement, dated July 25, 2024 (the “Separation Agreement”) in connection with Mr. Smithson’s previously disclosed departure from the Company on June 21, 2024.
On July 23, 2024, Don DeMarinis, Senior Vice President Sales, Americas and EMEA, of Agilysys, Inc. (the “Company”), notified the Company of his intention to retire effective as of August 30, 2024.
On July 25, 2024, Chirantan “CJ” Desai notified the Board of Directors (the “Board”) of MSCI Inc. (the “Company”) of his resignation from service as a director of the Company, effective the same date.
On July 24, 2024, Peter Davidson, a member of the Company’s Board of Directors (the “Board”) and member of the Audit, Nominating and Governance committees of the Board, informed the Company that he would be resigning as a director of the Board for personal reasons effective as of September 23, 2024.
Dr. Kjell Gruner, Chief Commercial Officer and President, Business Growth of Rivian Automotive, Inc. (the "Company"), notified the Company of his decision to resign to pursue other opportunities.
On July 23, 2024, Georgia R. Nelson provided notice to the Chairman of the Board of Directors (the “Board”) of Ball Corporation (the “Company”) of her desire to retire and, in connection therewith, tendered her resignation as a Class I member of the Board (the “Resignation”), with such Resignation to be effective as of the close of business on September 30, 2024 (the “Effective Date”).
Ms. Griffin is expected to replace Matthew Garff, a current member of the Board previously designated by Sun Cardinal who is expected to resign from the Board after a transition period by the end of the Company’s current fiscal year.
On July 24, 2024, Emil Assentato resigned as Chief Executive Officer and from the Board of Directors of Nukkleus Inc. (the “Company”), effective immediately.
On July 25, 2024, Avient Corporation (the “Company”) announced that Michael Garratt intended to retire from his position as Senior Vice President, President of Color, Additives & Inks - EMEA.
to fill the vacancy created by Ms. Michelle D. Wilson electing not to stand for reelection.
Departed
Lorna E. Nagler
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
Michael E. Longo
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
William G. Quinn
Other Named Officer
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Effective upon completion of the Merger, the following persons, who were named executive officers of the Company immediately prior to the Effective Time, are no longer officers of the Company: William G. Quinn, Benjamin A. Knighten and Robert Volke.
Departed
Linda Hubbard
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
James A. Hilt
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
Dorlisa K. Flur
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
Anthony F. Crudele
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
Terrance G. Finley
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
Karen S. Etzkorn
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Departed
Pamela J. Edwards
Director
HIBBETT INC
Effective
2024-07-25
Filed
July 25, 2024, 7:59 PM ET
Pursuant to the terms of the Merger Agreement, Anthony F. Crudele, Pamela J. Edwards, James A. Hilt, Ramesh Chikkala, Karen S. Etzkorn, Terrance G. Finley, Dorlisa K. Flur, Linda Hubbard, Michael E. Longo and Lorna E. Nagler ceased serving as members of the Company’s board of directors and each committee thereof.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.